Supplemental material
Open access
2,511
Views
1
CrossRef citations to date
0
Altmetric
Report
Antibody blockade of CD96 by distinct molecular mechanisms
Peter S. Leea Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USACorrespondence[email protected]
, Bryant Chaua Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USA
, Ishita Barmanb Therapeutic Discovery, 3T Biosciences, South San Francisco, Ca, USA
, Christine Beec Discovery Biology, Frontier Medicines, South San Francisco, CA, USA
, Aarti Jashnania Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USA
, Jason M. Hogana Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USA
, Barbara Aguilara Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USA
, Gavin Dollingera Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USA
, Arvind Rajpald Large Molecule Drug Discovery, Genentech Research and Early Development, South San Francisco, Ca, USA
& Pavel Stropa Discovery Biotherapeutics, Bristol Myers Squibb, Redwood City, CA, USACorrespondence[email protected]
show all
Article: 1979800
|
Received 07 Jul 2021, Accepted 09 Sep 2021, Published online: 01 Oct 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.